Further studies suggested that AS-IV may improve insulin resistance and lipid accumulation by regulating the PTP1B/IR/IRS-1 and PTP1B/SREBP-1c signaling pathways (Zhou et al., 2021). This evidence concerns the gene PTPN1 and Insulin resistance.